Upload Avatar (500 x 500)
Hong Yu
yu.hong@whu.edu.cn
English, Chinese, French
Hubei
Wuhan University
Medical School
  • 1987.9 - 1992.6 Bachelor of Medicine, Wuhan University Medical School (formerly Hubei Medical University)
  • 1994.9 - 1999.6 PhD in Cardiovascular Medicine, Wuhan University Medical School
  • 2001.10 - 2002.10 Postdoctoral Researcher, Nancy 1 University, France
  • 2003.7 - 2005.9 Postdoctoral Researcher, Cardiovascular Medicine, Vanderbilt University Medical Center, USA
  • 1992.07 - 1997.10 Assistant, Department of Biochemistry, Wuhan University Medical School
  • 1997.10 - 2000.07 Lecturer, Department of Biochemistry, Wuhan University Medical School
  • 2000.07 - 2005.11 Associate Professor, Department of Biochemistry and Molecular Biology, Wuhan University Medical School
  • 2005.12 - 2008.06 Professor, Department of Biochemistry and Molecular Biology, Wuhan University Medical School
  • 2008.06 - 2013.06 Professor, Department of Biochemistry and Molecular Biology, Wuhan University Medical School
  • 2013.06 - Present Professor, Department Head, Department of Biochemistry and Molecular Biology, Wuhan University Medical School
  • 2016 Advanced Female Faculty of Wuhan University
  • 2016 Third Prize, 16th Hubei Province Natural Science Excellent Academic Paper
  • 2017 Second Outstanding Teaching Performance Award, Wuhan University
  • 2018 Special Prize, First International Symposium on Cholesterol Reverse Transport
  • 2020 Second Prize, 5th National College Student Life Science Innovation and Entrepreneurship Competition (as a mentor)
Molecular mechanisms and prevention of atherosclerosis
Biomedical engineering technology and pharmaceutical research
  • Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice, Yu H*, 2020
  • Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice, Yu H*, 2018
  • Isoliquiritigenin attenuates atherogenesis in apolipoprotein E deficient mice, Yu H*, 2016
  • A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice, Yu H*, 2016
  • Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice, Yu H*, 2015
  • PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice, Yu H*, 2015
  • Effect of the apolipoprotein E mimetic peptide EpK on atherosclerosis in apoE-/- mice, Yu H*, 2015
Atherosclerosis Molecular Mechanisms Prevention Cardiovascular Diseases Biomedical Engineering Pharmaceutical Research Gene Engineering Oxidative Stress Metabolic Diseases Therapeutic Strategies

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.